Dr. Victoria Yvonne Bird, MD

Dr. Bird practices at Laboratory Corporation of America in Zephyrhills, Florida.

Dr. Bird's NPI, 1093856874, was assigned on February 12, 2007. Dr. Bird graduated from University of Wisconsin-Madison in 2000. Dr. Bird holds Florida license ME97879.

Dr. Bird's primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Dr. Bird's primary practice is Laboratory Corporation of America in Zephyrhills, Florida. Dr. Bird is also affiliated with HCA Florida North Florida Hospital. The medical group on file is North Florida Urology Associates. Dmand AI also links Dr. Bird to 1 more hospital, 3 home health agencies, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bird practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bird's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bird is board certified in urology by the American Board of Urology. Dr. Bird is licensed in Florida.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Bird treats.

CMS data shows 5,450 Medicare services from Dr. Bird across 19 procedure codes in 2024, for 441 Medicare patients. Medicare paid $289,898 for them.

CMS counts 441 Medicare patients who saw Dr. Bird in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bird's median patient age at 73, with 26% women.

In 2024, Dr. Bird wrote 1,360 Medicare Part D claims for 437 patients. 97% of them were for generic drugs. CMS names the drug for 1,245 of them, across 20 drugs with 11 or more claims each, at $46,118 in total drug cost. In 2023, CMS named 1,116 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bird for performance year 2024, reported individually. Dr. Bird accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bird as offering telehealth. CMS counts 20 procedures of prostate resection by Dr. Bird, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Bird, published from 2016 to 2020. 2017 was the busiest year, with 4. The most frequent topics are Kidney Calculi, Prostatic Neoplasms and Prostate-Specific Antigen. Dr. Bird's most frequent co-authors are Vincent Gerard Bird, MD, Rajinikanth Ayyathurai, MD and Robert Ira Carey, MD.

CMS Open Payments shows 108 general payments to Dr. Bird from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Profound Medical Corp. paid the most, $3,727.

Dmand AI lists 2 awards for Dr. Bird, most recently UF Patient Key Award in 2017.

Dr. Bird graduated from University of Wisconsin-Madison in 2000.

Dr. Bird is in network with 13 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.